A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
Status:
Completed
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This is a Phase 1, Randomized, Placebo-Controlled, Modified Parallel Design Multiple
Ascending Dose Study of NTRX 07 to Assess Safety and Tolerability and Pharmacokinetics in
Adult Healthy Volunteers and Subjects with MCI or Early AD. In addition, an exploratory study
of the effect of a high fat meal was conducted.